| Dr Scott Borkenhagen, | |
|
3722 Nazareth Rd, Easton, PA 18045-8340 | |
| (610) 250-8610 | |
| Not Available |
| Full Name | Dr Scott Borkenhagen |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 3722 Nazareth Rd, Easton, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184225237 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RP437458 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Scott Borkenhagen, 2723 Halleck Dr, Whitehall, PA 18052-3832 Ph: (610) 533-6477 | Dr Scott Borkenhagen, 3722 Nazareth Rd, Easton, PA 18045-8340 Ph: (610) 250-8610 |
News Archive
Investigators report no evidence of toxicity in the four hemophilia B patients enrolled to date in a gene therapy trial using a vector under development at St. Jude Children's Research Hospital and UCL (University College London) to correct the inherited bleeding disorder.
Isobel Coleman, senior fellow for U.S. Foreign Policy and director of the Civil Society, Markets and Democracy Initiative at the Council On Foreign Relations, reports on the council's website on maternal health in Afghanistan, writing that one out of 11 Afghan women is likely to die in childbirth during her lifetime; Afghan women are 200 times more likely to die giving birth than by a bomb or bullet. Not surprisingly, Save the Children this year ranked Afghanistan the worst country in the world to be a mother. Yet, there are some positive signs.
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today its unaudited third quarter financial results for the period ended September 30, 2011.
Celsion Corporation (NASDAQ:CLSN) announced today the Data Safety Monitoring Board ("DSMB") has reviewed the safety data from the first group of patients enrolled in its pivotal ThermoDox® Phase III clinical trial for primary liver cancer ("HEAT study") and has recommended that Celsion continue to enroll patients in the trial.
› Verified 5 days ago
Dr. Daniel James Kohler, D.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2467 Nazareth Rd, Easton, PA 18045 Phone: 610-258-3961 | |
Sharon Horvath, RPH, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 901 Northampton St, Easton, PA 18042 Phone: 610-868-6116 | |
Meredith Miranda, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3835 Dryland Way, Easton, PA 18045 Phone: 610-250-5281 | |
Joelle Nadine Harmonosky, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 301 Town Center Blvd, Easton, PA 18040 Phone: 610-559-1209 Fax: 844-411-6799 | |
Shawn Thomas Lynn, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 215 Town Center Blvd, Easton, PA 18040 Phone: 610-250-3651 | |
Samantha Rosenberg, CPHT Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3825 Sullivan Trl, Easton, PA 18040 Phone: 610-252-6756 | |
Mr. Michael Dennis Tercha, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 282 Line St, Easton, PA 18042 Phone: 610-515-9170 |